Effects of bitter melon (Momordica charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced rats

International Journal of Food Sciences and Nutrition

Volumn 67, Issue 6, 2016, Pages 686-695

  Zhu, Ying ^a   Bai, Juan ^a   Zhang, Yi ^a   Xiao, Xiang ^a   Dong, Ying ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Bitter melon; gut microbiota; pyrosequencing; rats; type 2 diabetes

Indexed keywords

BACTERIAL DNA; GLUCOSE BLOOD LEVEL; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA 16S; STREPTOZOCIN; STRESS ACTIVATED PROTEIN KINASE;

ADVERSE EFFECTS; ANIMAL; BACTEROIDES; BLOOD; CHEMISTRY; CLOSTRIDIALES; DIET; DIET THERAPY; DNA SEQUENCE; DOSE RESPONSE; EXPERIMENTAL DIABETES MELLITUS; FECES; FRUIT; GASTROINTESTINAL TRACT; GENETICS; GLUCOSE BLOOD LEVEL; INTESTINE FLORA; ISOLATION AND PURIFICATION; LIPID DIET; MALE; METABOLISM; MICROBIOLOGY; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RAT; RUMINOCOCCUS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ANIMALS; BACTEROIDES; BLOOD GLUCOSE; CLOSTRIDIALES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET; DIET, HIGH-FAT; DNA, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; FRUIT; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; INSULIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MOMORDICA CHARANTIA; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, RIBOSOMAL, 16S; RUMINOCOCCUS; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; STREPTOZOCIN;

EID: 84977125908     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637486.2016.1197185     Document Type: Article

References (36)

1. I.Ahmed, M.S.Lakhani, M.Gillett, A.John, H.Raza 2001. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica Charantia (Karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pr. 51:155–161.
2. F.Bäckhed, H.Ding, T.Wang, L.V.Hooper, G.Y.Koh, A.Nagy, C.F.Semenkovich, J.I.Gordon 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 101:15718–15723.
3. S.Brugman, F.Klatter, J.T.J.Visser, A.C.M.Wildeboer-Veloo, H.J.M.Harmsen, J.Rozing, N.Bos 2006. Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia. 49:2105–2108.
4. P.D.Cani, J.Amar, M.A.Iglesias, M.Poggi, C.Knauf, D.Bastelica, A.M.Neyrinck,. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 56:1761–1772.
5. P.D.Cani, R.Bibiloni, C.Knauf, A.Waget, A.M.Neyrinck, N.M.Delzenne, R.Burcelin 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 57:1470–1481.
6. P.D.Cani, N.M.Delzenne 2011. The gut microbiome as therapeutic target. Pharmacol Ther. 130:202–212.
7. A.Chao, J.Bunge 2004. Estimating the number of species in a stochastic abundance model. Biometrics. 58:531–539.
8. P.Dandona, A.Aljada, A.Bandyopadhyay 2004. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25:4–7.
9. N.M.Delzenne, P.D.Cani 2010. Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: potential interest of prebiotics. Int Dairy J. 20:277–280.
10. M.E.Dumas, R.H.Barton, A.Toye, O.Cloarec, C.Blancher, A.Rothwell, J.Fearnside,. 2006. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103:12511–12516.
11. S.M.Finegold, S.E.Dowd, V.Gontcharova, C.Liu, K.E.Henley, R.D.Wolcott, E.Youn,. 2010. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 16:444–453.
12. M.Freemark, D.Bursey 2001. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics. 107:E55.
13. A.Fuangchan, P.Sonthisombat, T.Seubnukarn, R.Chanouan, P.Chotchaisuwat, V.Sirigulsatien, K.Ingkaninan,. 2011. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J Ethnopharmacol. 134:422–428.
14. I.J.Good 1953. The population frequencies of species and the estimation of population parameters. Biometrika. 40:237–264.
15. N.J.Gotelli 2002. Ecology. Biodiversity in the scales. Nature. 419:575–576.
16. J.Grover, S.Yadav 2004. Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol. 93:123–132.
17. T.Hochdörfer, C.Tiedje, D.J.Stumpo, P.J.Blackshear, M.Gaestel, M.Huber 2013. LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP. Cell Signal. 25:1339–1347.
18. M.Igarashi, H.Wakasaki, N.Takahara, H.Ishii, Z.-Y.Jiang, T.Yamauchi, K.Kuboki,. 1999. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest. 103:185–195.
19. N.Jones 2011. Gut study divides people into three types. Nature. doi:10.1038/news.2011.249.
20. H.Kaneto, T.-A.Matsuoka, Y.Nakatani, D.Kawamori, T.Miyatsuka, M.Matsuhisa, Y.Yamasaki 2005. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes. J Mol Med. 83:429–439.
21. A.Kar, B.Choudhary, N.Bandyopadhyay 2003. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J Ethnopharmacol. 84:105–108.
22. M.Kato, A.Ishige, N.Anjiki, M.Yamamoto, Y.Irie, M.Taniyama, R.Kibe, J.Oka, Y.Benno, K.Watanabe. 2007. Effect of herbal medicine Juzentaihoto on hepatic and intestinal heat shock gene expression requires intestinal microflora in mouse. World J Gastroenterol. 13:2289–2297.
23. N.Larsen, F.K.Vogensen, F.W.J.Berg, D.S.Nielsen, A.S.Andreasen, B.K.Pedersen, W.A.Al-Soud, S.J.Sørensen, L.H.Hansen, M.Jakobsen. 2010. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 5:e9085.
24. R.E.Ley, F.Bäckhed, P.Turnbaugh, C.A.Lozupone, R.D.Knight, J.I.Gordon 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 102:11070–11075.
25. R.E.Ley, P.J.Turnbaugh, S.Klein, J.I.Gordon 2006. Microbial ecology: human gut microbes associated with obesity. Nature. 444:1022–1023.
26. A.Lim, D.Nikolic-Paterson, F.Ma, E.Ozols, M.Thomas, R.Flavell, R.Davis, G.Tesch 2009. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia. 52:347–358.
27. T.Miura, C.Itoh, N.Iwamoto, M.Kato, M.Kawai, S.R.Park, I.Suzuki 2001. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J Nutr Sci Vitaminol. 47:340–344.
28. H.Shi, M.V.Kokoeva, K.Inouye, I.Tzameli, H.Yin, J.S.Flier 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 116:3015–3025.
29. C.-C.Shih, C.-H.Lin, W.-L.Lin, J.-B.Wu 2009. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J Ethnopharmacol. 123:82–90.
30. P.J.Turnbaugh, M.Hamady, T.Yatsunenko, B.L.Cantarel, A.Duncan, R.E.Ley, M.L.Sogin, W.J.Jones, B.A.Roe, J.P.Affourtit,. 2008. A core gut microbiome in obese and lean twins. Nature. 457:480–484.
31. S.J.Wu, L.T.Ng 2008. Antioxidant and free radical scavenging activities of wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) in Taiwan. LWT-Food Sci Technol. 41:323–330.
32. X.Xiao, Y.Dong, Y.Zhu, H.Cui 2013. Bacterial diversity analysis of zhenjiang yao meat during refrigerated and vacuum-packed storage by 454 pyrosequencing. Curr Microbiol 66:398–405.
33. B.Xu, Y.Dong 2005. Determination on Total Saponins of Momordica Charantia L. by spectrophotometry. Food Sci. 10:165–169.
34. S.J.Yang, J.M.Choi, S.E.Park, E.J.Rhee, W.Y.Lee, K.W.Oh, S.W.Park, C.-Y.Park 2015. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats. J Nutr Biochem. 26:234–240.
35. X.Yin, J.Peng, L.Zhao, Y.Yu, X.Zhang, P.Liu, Q.Feng, Y.Hu, X.Pang. 2013. Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula. Syst Appl Microbiol. 36:188–196.
36. Y.Zhu, Y.Dong, X.Qian, F.Cui, Q.Guo, X.Zhou, Y.Wang, Y.Zhang, Z.Xiong. 2012. Effect of superfine grinding on antidiabetic activity of bitter melon powder. Int J Mol Sci. 13:14203–14218.